T-cell-based immunotherapy of autoimmune diseases

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Expert Review of Vaccines

• Publication date

  2013-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1586/erv.12.146PMID 23496669
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased levels of circulating Th17 cells in quiescent versus active Crohn's disease.

  2013cited by this paper
• The IL23/Th17 pathway as a therapeutic target in chronic inflammatory diseases.

  2012cited by this paper
• Functional stability of Foxp3+ regulatory T cells.

  2012cited by this paper
• Helper T cell diversity and plasticity.

  2012cited by this paper
• Induced Foxp3(+) regulatory T cells: a potential new weapon to treat autoimmune and inflammatory diseases?

  2012cited by this paper
• Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo

  2012cited by this paper
• Expression of Helios in Peripherally Induced Foxp3+ Regulatory T Cells

  2012cited by this paper
• Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β

  2012cited by this paper
• How (specific) would you like your T-cells today? Generating T-cell therapeutic function through TCR-gene transfer

  2012cited by this paper
• Brief report: inhibition of interleukin-6 function corrects Th17/Treg cell imbalance in patients with rheumatoid arthritis.

  2012cited by this paper
• The 20th anniversary of interleukin-2 therapy: bimodal role explaining longstanding random induction of complete clinical responses

  2012cited by this paper
• The symphony of the ninth: the development and function of Th9 cells.

  2012cited by this paper
• Action of RORs and their ligands in (patho)physiology.

  2012cited by this paper
• Chemokine receptors in the pathogenesis and therapy of psoriasis.

  2012cited by this paper
• Nature and nurture in Foxp3(+) regulatory T cell development, stability, and function.

  2012cited by this paper
• Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis.

  2012cited by this paper
• Defining the human T helper 17 cell phenotype.

  2012cited by this paper
• Interleukin‐23: as a drug target for autoimmune inflammatory diseases

  2012cited by this paper
• Immunoglobulin Analysis Tool: A Novel Tool for the Analysis of Human and Mouse Heavy and Light Chain Transcripts

  2012cited by this paper
• Th17 cell cytokine secretion profile in host defense and autoimmunity

  2012cited by this paper
• Application of IL-2 therapy to target T regulatory cell function.

  2012cited by this paper
• Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells

  2012cited by this paper
• Human Th17 subsets

  2012cited by this paper
• Induced Foxp 3 + regulatory T cells : a potential new weapon to treat autoimmune and inflammatory diseases ?

  2012cited by this paper
• Tocilizumab for the Treatment of Rheumatoid Arthritis and Other Systemic Autoimmune Diseases: Current Perspectives and Future Directions

  2012cited by this paper
• Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial

  2012cited by this paper
• Enforced IL-10 expression confers type 1 regulatory T cell (Tr1) phenotype and function to human CD4(+) T cells.

  2012cited by this paper
• The Cellular and Molecular Mechanisms of Immuno-Suppression by Human Type 1 Regulatory T Cells

  2011cited by this paper
• Deciphering the role of Th17 cells in human disease.

  2011cited by this paper
• Faculty Opinions recommendation of Fate mapping of IL-17-producing T cells in inflammatory responses.

  2011cited by this paper
• Fate mapping of interleukin 17-producing T cells in inflammatory responses

  2011cited by this paper
• Difference in Th1 and Th17 Lymphocyte Adhesion to Endothelium

  2011cited by this paper
• Polyclonal Treg cells modulate T effector cell trafficking

  2011cited by this paper
• Identification of T helper type 1–like, Foxp3+ regulatory T cells in human autoimmune disease

  2011cited by this paper
• Functional specialization of interleukin-17 family members.

  2011cited by this paper
• Human FoxP3+ regulatory T cells in systemic autoimmune diseases.

  2011cited by this paper
• The PDL1-PD1 Axis Converts Human TH1 Cells into Regulatory T Cells

  2011cited by this paper
• Human Regulatory T Cells with Alloantigen Specificity Are More Potent Inhibitors of Alloimmune Skin Graft Damage than Polyclonal Regulatory T Cells

  2011cited by this paper
• Regulatory T cells and Foxp3

  2011cited by this paper
• Active immunization against IL-23p19 improves experimental arthritis.

  2011cited by this paper
• Histone Deacetylase 9 Deficiency Protects against Effector T Cell-mediated Systemic Autoimmunity*

  2011cited by this paper
• Th17 lymphocytes traffic to the central nervous system independently of α4 integrin expression during EAE

  2011cited by this paper
• CD4+FOXP3+ T Regulatory Cells in Human Autoimmunity: More Than a Numbers Game

  2011cited by this paper
• Mechanisms controlling Th17 cytokine expression and host defense

  2011cited by this paper
• Therapeutic potential of anti-interleukin-17A aptamer: suppression of interleukin-17A signaling and attenuation of autoimmunity in two mouse models.

  2011cited by this paper
• Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activity

  2011cited by this paper
• Suppression of TH17 Differentiation and Autoimmunity by a Synthetic ROR Ligand

  2011cited by this paper
• In vivo Prevention of Transplant Arteriosclerosis by ex vivo Expanded Human Regulatory T Cells

  2010cited by this paper
• Expansion of regulatory T cells via IL‐2/anti‐IL‐2 mAb complexes suppresses experimental myasthenia

  2010cited by this paper
• Interleukin-6 inhibition for treatment of rheumatoid arthritis: A review of tocilizumab therapy

  2010cited by this paper
• Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis

  2010cited by this paper
• Aptamers as therapeutics

  2010cited by this paper
• Effector T cell plasticity: flexibility in the face of changing circumstances

  2010cited by this paper
• Interferons direct Th2 cell reprogramming to generate a stable GATA-3(+)T-bet(+) cell subset with combined Th2 and Th1 cell functions.

  2010cited by this paper
• IL‐22‐producing CD4+ T cells: Middle‐men between the immune system and its environment

  2010cited by this paper
• CCR6 recruits regulatory T cells and Th17 cells to the kidney in glomerulonephritis.

  2010cited by this paper
• Precarious Balance: Th17 Cells in Host Defense

  2009cited by this paper
• CD49d provides access to "untouched" human Foxp3+ Treg free of contaminating effector cells.

  2009cited by this paper
• The AP-1 transcription factor Batf controls TH17 differentiation

  2009cited by this paper
• The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment.

  2009cited by this paper
• IL-10 Deficiency Unleashes an Influenza-Specific Th17 Response and Enhances Survival against High-Dose Challenge1

  2009cited by this paper
• Immunomodulatory effects of deacetylase inhibitors: therapeutic targeting of FOXP3+ regulatory T cells

  2009cited by this paper
• Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor.

  2009cited by this paper
• In vivo expansion of T reg cells with IL-2–mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression

  2009cited by this paper
• Transcriptional regulatory networks in Th17 cell differentiation.

  2009cited by this paper
• Curing CNS autoimmune disease with myelin‐reactive Foxp3+ Treg

  2009cited by this paper
• Pre-differentiated Th1 and Th17 effector T cells in autoimmune gastritis: Ag-specific regulatory T cells are more potent suppressors than polyclonal regulatory T cells.

  2009cited by this paper
• Properties and origin of human Th17 cells.

  2009cited by this paper
• CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T‐cell recruitment to target tissues

  2009cited by this paper
• Leukocyte integrins and their ligand interactions

  2009cited by this paper
• Immunomodulatory drug FTY720 induces regulatory CD4+CD25+ T cells in vitro

  2009cited by this paper
• Plasticity of CD4+ T cell lineage differentiation.

  2009cited by this paper
• Human T regulatory cell therapy: take a billion or so and call me in the morning.

  2009cited by this paper
• Control of regulatory T cell lineage commitment and maintenance.

  2009cited by this paper
• Mechanisms of foxp3+ T regulatory cell-mediated suppression.

  2009cited by this paper
• Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions

  2009cited by this paper
• Inhibition of CCR6 Function Reduces the Severity of Experimental Autoimmune Encephalomyelitis via Effects on the Priming Phase of the Immune Response1

  2009cited by this paper
• How diverse--CD4 effector T cells and their functions.

  2009cited by this paper
• Human Th17 Cells Share Major Trafficking Receptors with Both Polarized Effector T Cells and FOXP3+ Regulatory T Cells1

  2008cited by this paper
• Multiple Sclerosis and Regulatory T Cells

  2008cited by this paper
• Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells.

  2008cited by this paper
• Interactions among the transcription factors Runx1, RORγt and Foxp3 regulate the differentiation of interleukin 17–producing T cells

  2008cited by this paper
• Differentiation of human TH-17 cells does require TGF-β!

  2008cited by this paper
• Deacetylase inhibition promotes the generation and function of regulatory T cells

  2007cited by this paper
• IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge

  2007cited by this paper
• Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype.

  2007cited by this paper
• Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model

  2007cited by this paper
• Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans

  2007cited by this paper
• IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells

  2007cited by this paper
• FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression

  2007cited by this paper
• Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation.

  2007cited by this paper
• Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production.

  2007cited by this paper
• Essential autocrine regulation by IL-21 in the generation of inflammatory T cells

  2007cited by this paper
• CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells

  2006cited by this paper
• Rapamycin Promotes Expansion of Functional CD4+CD25+FOXP3+ Regulatory T Cells of Both Healthy Subjects and Type 1 Diabetic Patients1

  2006cited by this paper
• Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis.

  2006cited by this paper
• A crucial role for interleukin (IL)-1 in the induction of IL-17–producing T cells that mediate autoimmune encephalomyelitis

  2006cited by this paper
• Induction of Tolerance in Type 1 Diabetes via Both CD4+CD25+ T Regulatory Cells and T Regulatory Type 1 Cells

  2006cited by this paper
• IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

  2005cited by this paper
• Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

  2005cited by this paper

• Optimization of Interleukin-10 incorporation for dendritic cells embedded in Poly(ethylene glycol) hydrogels.

  2024cites this paper
• Current knowledge of the immune reconstitution inflammatory syndrome in Whipple disease: a review

  2023cites this paper
• Adherent-invasive Escherichia coli LF82 aggravated intestinal inflammation in colitis mice by affecting the gut microbiota and Th17/Treg cell differentiation balance

  2023cites this paper
• Systemic inflammation and cortical neurochemistry in never-medicated first episode-psychosis individuals.

  2023cites this paper
• Recent Progress in Multiple Sclerosis Treatment Using Immune Cells as Targets

  2023cites this paper
• Application and prospect of targeting innate immune sensors in the treatment of autoimmune diseases

  2022cites this paper
• Exploring the role of immunotherapeutic drugs in autoimmune diseases: A comprehensive review.

  2021cites this paper
• Kuijieling-Containing Serum Regulates Th17 and Treg Cell Differentiation by Inhibiting STAT3 Signaling In Vitro

  2019cites this paper
• An overview on the methods of determining the activity of Indoleamine 2, 3-Dioxygenase 1

  2018cites this paper
• Kuijieling regulates the differentiation of Treg and Th17 cells to ameliorate experimental colitis in rats.

  2018cites this paper
• Animal models of allergen‐specific immunotherapy in food allergy: Overview and opportunities

  2018cites this paper
• Postmenopausal osteoporosis in rheumatoid arthritis: The estrogen deficiency-immune mechanisms link.

  2017cites this paper
• The tyrosine kinase inhibitor tyrphostin AG126 reduces activation of inflammatory cells and increases Foxp3+ regulatory T cells during pathogenesis of rheumatoid arthritis.

  2016cites this paper
• Pep19 drives epitope spreading in periodontitis and periodontitis-associated autoimmune diseases.

  2016cites this paper
• Short report Open Access

  2015cites this paper
• FoxP3+T regulatory cells in Rheumatoid arthritis and the imbalance of the Treg/TH17 cytokine axis

  2015cites this paper
• FoxP 3 + T regulatory cells in Rheumatoid arthritis and the imbalance of the Treg / TH 17 cytokine axis

  2015cites this paper
• Atheroprotective immunity and cardiovascular disease: therapeutic opportunities and challenges

  2015cites this paper
• Deletion of CD24 Impairs Development of Heat Shock Protein gp96–Driven Autoimmune Disease through Expansion of Myeloid-Derived Suppressor Cells

  2014cites this paper
• Athero-protective immunity and cardiovascular disease: therapeutic opportunities and challenges

  2014cites this paper
• Ethyl Acetate Extract from Celastrus aculeatus Merr. Suppresses Synovial Inflammation in Adjuvant Arthritis Rats through Apoptosis Induction of CD4+CD25+FOXP3+ T Cells

  2014cites this paper
• Fragments of truth: T-cell targets of polyclonal immunoglobulins in autoimmune diseases.

  2014cites this paper
• Inhibitory effects of heat shock protein 90 blockade on proinflammatory human Th1 and Th17 cell subpopulations

  2014cites this paper
• Statins: from cholesterol-lowering drugs to novel immunomodulators for the treatment of Th17-mediated autoimmune diseases.

  2014influential citation
• The interleukin-23/interleukin-17 axis and the role of Treg/ Th17 cells in rheumatoid arthritis and joint destruction

  2013cites this paper
• Therapeutic vaccines and immunotherapies: current challenges and new frontiers

  2013cites this paper